: Presse & Downloads

Presse & Downloads

Die Informationen auf dieser Seite sind nur für Medienvertreter und Investoren bestimmt.

Kontakt:

Michael Donhofer
Director Global Marketing & Public Relations
Mobile: +43 676 84 68 68 823
E-mail: michael.donhofer@croma.at

Internationale Pressemitteilungen

PhilArt Natali 0179 icv2 RZ

Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators

Adding a complete range of rejuvenating skin boosters to our…

2023 04 17 11 45 15

AMWC 2023: Croma-Pharma to present recent clinical data and new range of skin boosters

At the AMWC (Aesthetic & Anti-aging Medicine World Congress) 2023,…

Croma-Pharma: Daniela Rudowitz New Global Medical Director

Dr. Daniela Rudowitz, BCMAS, will be the new Global Medical…

Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter

Company reports strong financial results for 2022 with 27% revenue…

Halbe Breite 1000x667 LETYBO v24

Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets

Croma (Croma-Pharma® GmbH) announced today that it has received marketing…

Pliaglis Local Anaesthesia

Croma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe

The launch is preceded by an exclusive licensing agreement for…

010 20221230 Theresia Pircher v2

Croma-Pharma: Theresia Pircher new global sustainability director

Theresia Pircher, MSc, is the new global sustainability director at…

Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China

Croma-Pharma® (‘Croma’) announced today that in June the first patient…

DSC2300 LO1 sRGB half1

Croma-Pharma: New brand identity

Croma-Pharma® (‘Croma’), a global player in the dynamically growing market…

Halbe Breite 1000x667 LETYBO v22

Croma-Pharma completes launch of botulinum toxin in eleven European markets

Croma is one of four companies in Europe to have…

Croma-Pharma is expanding its management team

Peter Haidenek new CEO and CFO

Daniel de Boer for business…

Halbe Breite 1000x667 LETYBO v24

Croma-Pharma completed the decentralized procedure for its botulinum toxin to treat glabellar lines

By adding its own botulinum toxin to the already broad…

Nationale Pressemitteilungen

Downloads

Croma-Pharma: Press Kit Company & History ()

Logo Croma-Pharma ()

Andreas Prinz (CEO Croma-Pharma) ()

Peter Haidenek (CFO Croma-Pharma) ()

Croma-Pharma: Andreas Prinz (CEO) & Peter Haidenek (CFO) ()

R&D Croma-Pharma 1 ()

R&D Croma-Pharma 2 ()

Headquarter Croma-Pharma 1 ()

Headquarter Croma-Pharma 2 (3.7 MB)

Headquarter Croma-Pharma 3 ()

Croma-Pharma Minimally Invasive Treatments ()

Croma-Pharma Consultation ()

Manufacturing Croma-Pharma ()